(866) 744-0454 Call us Start 2-minute check
Portrait of Branden Staller, MD

Physician and author

Branden Staller, MD

Branden Staller, MD, is a family medicine physician who evaluates men for testosterone deficiency and builds and manages their treatment plans.

Credential
MD, family medicine

About Branden

During his family medicine residency at BronxCare Hospital, men's health became his focus. Other residents sent their own patients to him for hormone and men's health consultations, and he used his lecture slots to teach the subject.

He earned his medical degree at St. George's University School of Medicine. His care starts with a proper workup, symptoms and morning lab tests, and a plan built for the individual patient.

Care Branden provides

Testosterone therapy

Guides

Wegovy® is a registered trademark of Novo Nordisk A/S. Vitality Testosterone Replacement Therapy is not affiliated with or endorsed by Novo Nordisk A/S. Foundayo™ is a trademark of Eli Lilly and Company. Vitality Testosterone Replacement Therapy is not affiliated with or endorsed by Eli Lilly and Company.

See a provider

Prescription treatment requires an evaluation by a licensed healthcare provider, who decides whether treatment is appropriate for you. Not everyone qualifies. Completing an assessment, booking a visit, or paying a fee does not guarantee a prescription.

Important safety information

Testosterone is FDA-approved for men with low testosterone caused by certain medical conditions. Its safety and effectiveness for low testosterone due to aging alone have not been established. Testosterone can raise blood pressure and red blood cell count, reduce sperm production and fertility, and requires monitoring of the prostate and blood levels. Your provider will review the benefits and risks and monitor you with regular labs.

Testosterone is a controlled substance because it can be misused. Abuse and dependence have been reported, mostly at doses above those prescribed. Take it only as your provider directs.

Testosterone is a Schedule III controlled substance. Depending on your state, and on federal telemedicine rules that are currently set to change after December 31, 2026, an in-person exam may be required before or during treatment.

Read the full Important Safety Information for testosterone